T&L Co. Ltd (340570) - Cash Flow Conversion Efficiency
Based on the latest financial reports, T&L Co. Ltd (340570) has a cash flow conversion efficiency ratio of 0.049x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩9.68 Billion ≈ $6.56 Million USD) by net assets (₩199.09 Billion ≈ $134.92 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 340570 net asset quality index to measure how much of total assets are equity-financed.
T&L Co. Ltd - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how T&L Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of T&L Co. Ltd to evaluate the quality of earnings relative to operating cash generation.
T&L Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of T&L Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bear Creek Mining Corporation
V:BCM
|
0.192x |
|
Rezolute Inc
NASDAQ:RZLT
|
-0.159x |
|
Moury Construct SA
BR:MOUR
|
0.210x |
|
AIM Industrial Growth Freehold and Leasehold Real Estate Investment Trust
BK:AIMIRT
|
-0.073x |
|
China Lilang Limited
F:5LX
|
0.070x |
|
KNEAT.COM INC.
F:FOBK
|
-0.047x |
|
Experian PLC
LSE:EXPN
|
0.251x |
|
National CineMedia Inc
NASDAQ:NCMI
|
0.001x |
Annual Cash Flow Conversion Efficiency for T&L Co. Ltd (2018–2024)
The table below shows the annual cash flow conversion efficiency of T&L Co. Ltd from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see T&L Co. Ltd (340570) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩171.44 Billion ≈ $116.18 Million |
₩46.57 Billion ≈ $31.56 Million |
0.272x | +7.98% |
| 2023-12-31 | ₩129.55 Billion ≈ $87.80 Million |
₩32.59 Billion ≈ $22.09 Million |
0.252x | +73.19% |
| 2022-12-31 | ₩106.07 Billion ≈ $71.88 Million |
₩15.41 Billion ≈ $10.44 Million |
0.145x | -31.15% |
| 2021-12-31 | ₩90.09 Billion ≈ $61.05 Million |
₩19.01 Billion ≈ $12.88 Million |
0.211x | +62.45% |
| 2020-12-31 | ₩71.95 Billion ≈ $48.76 Million |
₩9.34 Billion ≈ $6.33 Million |
0.130x | -44.91% |
| 2019-12-31 | ₩33.23 Billion ≈ $22.52 Million |
₩7.83 Billion ≈ $5.31 Million |
0.236x | +0.50% |
| 2018-12-31 | ₩27.24 Billion ≈ $18.46 Million |
₩6.39 Billion ≈ $4.33 Million |
0.235x | -- |
About T&L Co. Ltd
T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was foun… Read more